Study: European drug industry moving toward greater transparency

11/12/2013 | PharmaTimes (U.K.)

Of 807 clinical trials approved by the European Medicines Agency, 77% disclosed their results within a year of completion or of regulatory approval –- a figure that rose to 89% by January 2013, according to a study by the Association of the British Pharmaceutical Industry. "[W]e fully expect to see the trend towards greater transparency continue on this positive trajectory," said ABPI chief executive Stephen Whitehead. The study appeared in the journal Current Medical Research and Opinion.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ